drugset / Trial / NCT05272683

Drug-drug Interaction Study with GLPG3667 and Itraconazole in Healthy Subjects

NCT05272683 ↗

Phase 1 Completed 14 enrolled Lakefront Biotherapeutics NV
NaSingle-groupOpen-labelBasic science

Summary

The main purpose of this study is to determine the effect of itraconazole on the amount of GLPG3667 that gets into the blood when the 2 drugs are administered together compared to when GLPG3667 is administered alone.

Timeline

Start
2022-02-28
Primary completion
2022-04-01
Completion
2022-04-22

Drugs

EvaluationDrugModalityDoseRoute
Subject GLPG3667 Small molecule — —
Subject Itraconazole Small molecule — —

Indications

No indication recorded.